Chem-Bio Informatics Journal
Online ISSN : 1347-0442
Print ISSN : 1347-6297
Original
Molecular Discrimination of Barbital Enantiomer at the Propofol Binding Site of the Human β3 Homomeric GABAA Receptor
Tomoyoshi SetoMinoru KatoKen Koyano
Author information
JOURNALS FREE ACCESS

2018 Volume 18 Pages 154-163

Details
Abstract

Intravenous anesthetic barbitals act on the GABAA receptor, and this receptor is the principal molecular target of loss of consciousness. Their action and side effects differ according to the enantiomer. Elucidation of their enantiomeric action is essential for a safe anesthetic agent. This study investigates molecular mechanisms of discrimination of enantiomeric barbital in the binding site of the GABAA receptor. Amobarbital, (R)-, (S)-pentobarbital, and (R)-, (S)-isobarbital bonded to the TM2-TM2’ transmembrane domain (TMD), i.e., the propofol binding site. There was a 2.9 kcal mol-1 difference in enantiomeric pentobarbital bindings. Pentobarbital discrimination in the TM2-TM2’ TMD site was caused not only by the barbital ring’s hydrogen-bond, but also by steric fittings of the methyl-group adjacent to the chiral carbon atom.

Information related to the author
Licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) : The images, videos or other third party material in this article are also included in the article’s Creative Commons license.To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
Previous article Next article
feedback
Top